昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603127 昭衍新药

未开盘 04-24 09:30:00

{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":17.5,"timestamp":1713920556000,"preClose":17.5,"halted":0,"volume":0,"delay":0,"floatShares":630000000,"shares":750000000,"eps":-0.3738,"marketStatus":"未开盘","marketStatusCode":0,"change":0,"latestTime":"04-24 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.3738,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713922200000},"adr":0,"adjPreClose":17.5,"symbolType":"stock","openAndCloseTimeList":[[1713922200000,1713929400000],[1713934800000,1713942000000]],"highLimit":19.25,"lowLimit":15.75,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749888699,"pbRate":1.59,"roa":"--","roe":"4.82%","epsLYR":0.53,"marketValue":13123000000,"floatMarketCap":11033000000,"peRate":-46.816478,"changeRate":0,"turnoverRate":0,"status":2},"requestUrl":"/m/hq/s/603127","defaultTab":"news","newsList":[{"id":"2429912787","title":"昭衍新药获融资买入0.32亿元，近三日累计买入0.59亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912787","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429912787?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:21","pubTimestamp":1713918104,"startTime":"0","endTime":"0","summary":"4月23日，沪深两融数据显示，昭衍新药获融资买入额0.32亿元，居两市第212位，当日融资偿还额0.22亿元，净买入922.46万元。最近三个交易日，19日-23日，昭衍新药分别获融资买入0.15亿元、0.12亿元、0.32亿元。融券方面，当日融券卖出24.42万股，净卖出19.09万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042408214787a82763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042408214787a82763&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429538641","title":"昭衍新药大幅上涨 美中宜和医疗集团进入全新发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2429538641","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2429538641?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:42","pubTimestamp":1713850928,"startTime":"0","endTime":"0","summary":"消息解读美中宜和医疗集团创始人兼首席执行官胡澜博士在“华章蜕变新质启航——美中宜和18周年媒体沟通会”上宣布，经过18年的发展，美中宜和已经完成了由妇儿专科医疗向更为综合的医疗平台的华丽转身。2024年第四季度，即将投入运行的大型三级医院综合体，标志着美中宜和进入全新发展阶段。此外，美中宜和在各个学科都引入先进的医疗理念，尝试诊疗模式上的创新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423135623792283ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423135623792283ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429916872","title":"昭衍新药04月22日主力资金流出24万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2429916872","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429916872?lang=zh_cn&edition=full","pubTime":"2024-04-22 15:19","pubTimestamp":1713770376,"startTime":"0","endTime":"0","summary":"04月22日, 昭衍新药股价涨1.13%，报收16.97元，成交金额1.53亿元，换手率1.43%，振幅5.01%，量比0.57。昭衍新药今日主力资金净流出24万元，连续3日净流出，上一交易日主力净流出1906万元，今日环比减少98.74%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.00%，平均跌幅为2.22%。该股近5个交易日下跌4.56%，主力资金累计净流出4913万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1.41亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042215384987a03629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042215384987a03629&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429969671","title":"南向资金4月19日净买入昭衍新药40.14万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429969671","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429969671?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:31","pubTimestamp":1713749478,"startTime":"0","endTime":"0","summary":"4月19日, 南向资金增持昭衍新药40.14万股，连续5日增持。截止当日收盘，港股通共持有昭衍新药3867.31万股，占流通股32.49%。港股通增持金额前五个股分别为腾讯控股、中国移动、建设银行、中国银行、中广核电力。昭衍新药近5个交易日下跌1.50%，港股通累计增持112.67万股；近20个交易日下跌7.65%，港股通累计增持245.63万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422094317879ed34e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422094317879ed34e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428637291","title":"昭衍新药：与专业投资机构合作设立产业基金，已签署合伙协议，公司实际认缴出资2.99亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2428637291","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2428637291?lang=zh_cn&edition=full","pubTime":"2024-04-19 18:42","pubTimestamp":1713523377,"startTime":"0","endTime":"0","summary":"4月19日消息， 昭衍新药 公告，公司已与无锡国联产业投资私募基金管理有限公司、北京宏儒和愉投资管理有限公司、无锡市创新投资集团有限公司、江苏原力产业投资有限公司及香塘合舆（北京）科技有限公司签署《无锡金易赋新 生物医药 创业投资合伙企业（有限合伙）有限合伙协议》。基金认缴出资总额为10亿元人民币，公司作为有限合伙人最终实际认缴出资2.99亿元人民币，占有限合伙29.90%份额，出资方式为货币出资。本基金尚需履行中国证券投资基金业协会的登记备案等手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191850278b3ac679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191850278b3ac679&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428399221","title":"昭衍新药涨6.86%，中国银河二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2428399221","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428399221?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:43","pubTimestamp":1713343406,"startTime":"0","endTime":"0","summary":"今日昭衍新药涨6.86%，收盘报17.76元。2024年4月1日，中国银河研究员程培,闫晓松发布了对昭衍新药的研报《公司整体运营稳健，利润阶段性承压》，该研报对昭衍新药给出“买入”评级。此外，中泰证券研究员祝嘉琦,崔少煜，国信证券研究员彭思宇,张佳博近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中国银河的程培。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041716512187881e5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041716512187881e5d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428233456","title":"医疗服务行业盘中拉升，昭衍新药涨6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428233456","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428233456?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:44","pubTimestamp":1713318269,"startTime":"0","endTime":"0","summary":"04月17日，医疗服务行业盘中拉升，截至09点44分，医疗服务行业整体指数上涨2.02%，报4532.820点。从个股上来看，该行业的成分股中，昭衍新药涨6.38%，兰卫医学、成都先导等6只股涨幅超过5%。从资金上来看，截止发稿，医疗服务行业主力净流入为-897.05万，其中爱尔眼科受到资金热捧，主力净流入1568.37万；拉长时间线来看，该板块近20日主力资金净流入-157.16亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041709442987e811c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041709442987e811c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427198478","title":"昭衍新药04月16日遭主力抛售2602万元 环比增加101.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427198478","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427198478?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:19","pubTimestamp":1713251942,"startTime":"0","endTime":"0","summary":"04月16日, 昭衍新药股价跌6.52%，报收16.62元，成交金额3.05亿元，换手率2.81%，振幅9.56%，量比0.88。昭衍新药今日主力资金净流出2602万元，连续5日净流出，上一交易日主力净流出1289万元，今日环比增加101.86%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为50.00%，平均跌幅为2.43%。该股近5个交易日下跌12.34%，主力资金累计净流出1.22亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1.91亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161537138b296dfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161537138b296dfe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427862779","title":"昭衍新药创1月新低 近半年5家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427862779","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2427862779?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:41","pubTimestamp":1713235299,"startTime":"0","endTime":"0","summary":"04月16日，昭衍新药股价大幅下跌，截至10点41分，昭衍新药下跌5.06%，报16.88元/股，创近1月新低，成交1.70亿元，换手率1.54%，振幅7.87%。此外，数据统计显示，近半年内5家券商给予增持建议，15家券商给予买入建议。北向资金方面，昭衍新药04月15日获得北向资金减持21.52万股，截至04月15日，北向资金当前共持有昭衍新药945.25万股，市值1.60亿元，持股占流通股比为1.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161053327a5305ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161053327a5305ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427652928","title":"CRO概念盘中跳水，昭衍新药跌2.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427652928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427652928?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:03","pubTimestamp":1713233001,"startTime":"0","endTime":"0","summary":"04月16日，CRO概念盘中跳水，截至10点03分，CRO概念整体指数下跌5.05%，报345.950点。从个股上来看，该概念的成分股中，昭衍新药跌2.70%，泰格医药、诺泰生物、博腾股份跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-2.02亿，其中华测检测受到资金热捧，主力净流入559.41万；拉长时间线来看，该板块近20日主力资金净流入-133.07亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161003217a52fd3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161003217a52fd3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426449274","title":"昭衍新药04月12日主力资金流出1803万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426449274","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426449274?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:19","pubTimestamp":1712906353,"startTime":"0","endTime":"0","summary":"04月12日, 昭衍新药股价跌3.93%，报收18.35元，成交金额3.13亿元，换手率2.67%，振幅5.86%，量比0.91。昭衍新药今日主力资金净流出1803万元，连续3日净流出，上一交易日主力净流出2294万元，今日环比减少21.40%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.00%，平均跌幅为2.43%。该股近5个交易日上涨1.83%，主力资金累计净流出2593万元；近20日主力资金累计净流入106万元，其中净流入天数为6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121538528b159acc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121538528b159acc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426547944","title":"北向资金4月10日净买入昭衍新药22.50万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426547944","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426547944?lang=zh_cn&edition=full","pubTime":"2024-04-11 09:30","pubTimestamp":1712799028,"startTime":"0","endTime":"0","summary":"4月10日, 北向资金增持昭衍新药22.50万股，连续5日增持。截止当日收盘，沪股通共持有昭衍新药969.49万股，占流通股1.53%。沪股通增持金额前五个股分别为工业富联、济川药业、中国平安、兴业银行、福莱特。昭衍新药近5个交易日上涨1.80%，沪股通累计增持131.94万股；近20个交易日上涨8.11%，沪股通累计减持110.17万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110933518b0d60f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110933518b0d60f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426430674","title":"昭衍新药04月10日收涨1.27% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2426430674","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426430674?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:19","pubTimestamp":1712733552,"startTime":"0","endTime":"0","summary":"04月10日, 昭衍新药股价涨1.27%，报收19.20元，成交金额6.04亿元，换手率5.01%，振幅3.59%，量比2.39。该股近5个交易日上涨1.80%，主力资金累计净流出317万元；近20日主力资金累计净流入2600万元，其中净流入天数为6日。该股主力净额占比0.35%，A股市场排名4846/5000，低于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410153911875f2afd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410153911875f2afd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426436467","title":"生物疫苗概念盘中拉升，昭衍新药涨1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426436467","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426436467?lang=zh_cn&edition=full","pubTime":"2024-04-10 14:25","pubTimestamp":1712730355,"startTime":"0","endTime":"0","summary":"04月10日，生物疫苗概念盘中拉升，截至14点25分，生物疫苗概念整体指数上涨0.50%，报1933.330点。从个股上来看，该概念的成分股中，昭衍新药涨1.16%，梅花生物、海普瑞、君正集团涨幅居前。从资金上来看，截止发稿，生物疫苗概念主力净流入为-2.77亿，其中梅花生物受到资金热捧，主力净流入4504.66万；拉长时间线来看，该板块近20日主力资金净流入-17.32亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041014255587e7f35b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041014255587e7f35b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426174433","title":"昭衍新药获融资买入0.23亿元，近三日累计买入0.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426174433","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426174433?lang=zh_cn&edition=full","pubTime":"2024-04-10 08:11","pubTimestamp":1712707902,"startTime":"0","endTime":"0","summary":"4月9日，沪深两融数据显示，昭衍新药获融资买入额0.23亿元，居两市第302位，当日融资偿还额0.41亿元，净卖出1861.28万元。最近三个交易日，3日-9日，昭衍新药分别获融资买入0.16亿元、0.25亿元、0.23亿元。融券方面，当日融券卖出25.07万股，净卖出22.56万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410081153875ca24b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410081153875ca24b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426161429","title":"太平洋给予昭衍新药买入评级 海外业务增速亮眼 新签项目数环比改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2426161429","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2426161429?lang=zh_cn&edition=full","pubTime":"2024-04-09 18:35","pubTimestamp":1712658915,"startTime":"0","endTime":"0","summary":"太平洋04月09日发布研报称，给予昭衍新药（603127.SH，最新价：18.96元）买入评级。评级理由主要包括：1）全年收入稳定增长，海外业务增速亮眼；2）不断加大客户拓展力度，新签项目数环比改善；3）市占率保持行业领先，细分领域保持竞争优势。风险提示：新签订单或新增项目数不及预期风险、新业务或新客户拓展不及预期风险、竞争加剧风险、产能投放不及预期风险、政策风险、生物资产公允价值变动风险等。AI点评：昭衍新药近一个月获得3份券商研报关注，买入1家。文章来源：每日经济新闻原标题：太平洋给予昭衍新药买入评级，海外业务增速亮眼，新签项目数环比改善","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040918491687599a85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040918491687599a85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426217159","title":"涨停揭秘 | 昭衍新药首板涨停，封板资金6286.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426217159","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426217159?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:34","pubTimestamp":1712651667,"startTime":"0","endTime":"0","summary":"4月9日，昭衍新药收盘首板涨停，截至当日收盘，昭衍新药报18.96元/股，成交额3.46亿元，总市值142.18亿元，封板资金6286.29万元。目前，公司已经建立了体外和体内药效筛选评价平台以及早期成药性筛选评价平台，为创新药企提供早期发现服务。业绩方面，2023年1月-12月，昭衍新药实现营业收入23.76亿元，同比增长4.78%；归属净利润3.97亿元，同比减少63.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091634388758f479&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091634388758f479&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426153308","title":"昭衍新药04月09日主力净流入7362万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2426153308","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426153308?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:18","pubTimestamp":1712647130,"startTime":"0","endTime":"0","summary":"04月09日, 昭衍新药股价涨9.98%，报收18.96元，成交金额3.46亿元，换手率3.02%，振幅10.90%，量比1.60。昭衍新药今日主力资金净流入7362万元，上一交易日主力净流出1628万元。该股近5个交易日上涨4.87%，主力资金累计净流入3796万元；近20日主力资金累计净流入7542万元，其中净流入天数为7日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091530398b023823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091530398b023823&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426131244","title":"CRO概念盘中拉升，昭衍新药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2426131244","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426131244?lang=zh_cn&edition=full","pubTime":"2024-04-09 14:31","pubTimestamp":1712644264,"startTime":"0","endTime":"0","summary":"04月09日，CRO概念盘中拉升，截至14点31分，CRO概念整体指数上涨3.04%，报396.940点。从个股上来看，该概念的成分股中，昭衍新药涨停，普蕊斯、宣泰医药等9只股涨幅超过5%。从资金上来看，截止发稿，CRO概念主力净流入为-1.59亿，其中泰格医药受到资金热捧，主力净流入8848.66万；拉长时间线来看，该板块近20日主力资金净流入-100.95亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091431047a518c6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091431047a518c6f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","stockEarnings":[{"period":"1week","weight":0.0529},{"period":"1month","weight":-0.0657},{"period":"3month","weight":-0.0741},{"period":"6month","weight":-0.2222},{"period":"1year","weight":-0.529},{"period":"ytd","weight":-0.2619}],"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"74988万元","compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":-0.0085},{"period":"3month","weight":0.0713},{"period":"6month","weight":0.0113},{"period":"1year","weight":-0.0774},{"period":"ytd","weight":0.0158}],"survey":"　　北京昭衍新药研究中心股份有限公司主营业务专注于药物全生命周期的安全性评价和监测服务，其药物临床前研究服务为公司的核心业务，主要内容包括药物非临床安全性评价服务、药效学研究服务、动物药代动力学研究服务和药物筛选。公司是中国首家通过美国FDAGLP检查，并同时具有AAALAC（国际实验动物福利审查认证协会）认证和中国CFDA的GLP认证资质的专业新药临床前安全性评价机构。所提供的试验报告和安全性数据已被美国FDA和国际上其他国家药监机构以及中国CFDA认可并用以支持在各自国家所开展的临床研究。","serverTime":1713920558114,"listedPrice":12.51,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,603127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}